These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4032804)

  • 1. [The levels of fibrinopeptide A and fibrinopeptide B beta in the urine from patients with chronic glomerulonephritis during urokinase therapy].
    Miura M; Tomino Y; Inoue W; Tamura S; Nomoto Y; Sakai H; Itoh K
    Rinsho Byori; 1985 Jun; 33(6):652-6. PubMed ID: 4032804
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
    Miura M; Tomino Y; Inoue W; Yagame M; Tamura S; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Oct; 11(4):273-7. PubMed ID: 3617111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new and sensitive method to detect acute rejection in renal transplantation.
    Kano T; Orihara A; Morozumi K; Uchida K; Yamada N; Tominaga Y; Kawai M; Takagi H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1691-4. PubMed ID: 3547877
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significance of urinary fibrinopeptide A and fibrinopeptide B-beta 15-42 in chronic rejection and nephrotoxicity of renal allograft recipients immunosuppressed with cyclosporine.
    Morozumi K; Kano T; Kobayashi M; Shinmura I; Yoshida A; Fujinami T; Otaguro K; Uchida K; Yamada N; Tominaga Y
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1791-4. PubMed ID: 3547884
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effect of urokinase on chronic glomerulonephritis (group study).
    Abe T
    New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):123-32. PubMed ID: 16302698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of urokinase therapy in patients with glomerulonephritis and nephrotic syndrome. Trial at multiple institutes in Japan].
    Tomura S; Takeuchi J; Tanaka K
    Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):97-121. PubMed ID: 6376892
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the urokinase treatment in patients with glomerulonephritis and nephrotic syndrome].
    Konishi K; Kato E; Iyori S; Higashi F
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):429-44. PubMed ID: 6750187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measurement of urinary fibrinopeptide A (FPA)--clinical application, especially to renal disease (author's transl)].
    Oka H
    Nihon Jinzo Gakkai Shi; 1979 Oct; 21(10):1125-39. PubMed ID: 529611
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinopeptide A in urine from patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis--evidence for dephosphorylation and carboxyterminal degradation of the peptide by the kidney.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Aken WG; van Mourik JA
    Thromb Haemost; 1985 Dec; 54(4):792-8. PubMed ID: 4089813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical importance of determination of the products of decomposition of fibrin and fibrinogen in urine in patients with glomerulonephritis].
    Belitskaia GA; Ena IaM; Varetskaia TV; Tsynkalevskaia SN; Tsariuk LA
    Ter Arkh; 1975; 47(4):46-50. PubMed ID: 1145480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1999; 45(2):158-64. PubMed ID: 10378306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advance in the treatment of diabetic nephropathy: anticoagulant therapy.
    Kaizu K; Uriu K; Hashimoto O; Eto S
    J Diabet Complications; 1991; 5(2-3):92-4. PubMed ID: 1770065
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of coagulative and fibrinolytic factors in peripheral and ovarian veins among ovarian cancer patients].
    Ino Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2417-26. PubMed ID: 3130448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of the trace levels of urinary fibrinopeptides by high-performance capillary electrophoresis].
    Cheng MG; Hao YH; Cao JH; Liang T; Zhou KY; Ling GX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1005-7. PubMed ID: 18583249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the structure of canine fibrinogen.
    Birken S; Wilner GD; Canfield RE
    Thromb Res; 1975 Oct; 7(4):599-610. PubMed ID: 1198547
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
    Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
    Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urokinase in acute and chronic arterial diseases].
    Ciammaichella A; Gori M; Bonacci I
    Clin Ter; 1981 Nov; 99(4):377-81. PubMed ID: 7030591
    [No Abstract]   [Full Text] [Related]  

  • 19. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
    Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.